Data published in Cancer Research show Secarna Pharmaceuticals’ LNAplus(TM) ASOs targeting metadherin significantly slow progression and metastasis of…

Globe Newswire

during the forecast period. The growth of this market is majorly driven by the growing awareness about the benefits of cell culture-based vaccines, increasing demand for monoclonal antibodies (mAbs), funding for cell-based research, growing preference for single-use technologies, and the launch of advanced cell culture products.New York, Dec. 08, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Cell Culture Market by Product, Application, End User - Global Forecast to 2025" - https://www.reportlinker.com/p03665912/?utm_source=GNW On the other hand, the high cost of cell biology research and the lack of proper infrastructure for cell-based research activities are the major factors restraining this markets growth.Based on product, the consumables segment holds the largest market share during the forecast period.Based on product, the cell culture market is segmented into equipment and consumables.The consumables segment accounted for the largest market share in 2019 and is expected to register the highest CAGR during the forecast period.The dominant share and high growth of the consumables segment can be attributed to the repeated purchase of consumables and increased funding for cell-based research.Based onapplication, thebiopharmaceutical productionsegment is expected to register the highest CAGR during the forecast period.Based on application, the cell culture market is categorized into biopharmaceutical production, stem cell research, diagnostics, drug screening & development, tissue engineering and regenerative medicine, and other applications. The biopharmaceutical production application segment is expected to register the highest CAGR during the forecast period.The high growth of this segment is attributed to the commercial expansion of major pharmaceutical companies, growing regulatory approvals for the production of cell culture-based vaccines, and the increasing demand for monoclonal antibodies (mAbs).Pharmaceutical &Biotechnology companies end user segment is expected to grow at the highest CAGR in the cell culture market during the forecast periodBased on end users, the cell culture market is segmented into pharmaceutical & biotechnology companies, academic & research institutes, hospitals and diagnostic centers, and cell banks. The pharmaceutical & biotechnology companies segment is expected to witness the highest growth during the forecast period. The growing use of single-use technologies, the increasing number of regulatory approvals for cell culture-based vaccines, and the presence of a large number of pharmaceutical players in this market are some of the factors driving the cell culture market for this end user segmentNorth America is expected to account for the largest share of the cell culture market in 2019In 2019, North America accounted for the largest share of the cell culture market, followed by Europe, the Asia Pacific, Latin America, and the Middle East & Africa. The large share of this market segment can be attributed to thegrowing regulatory approvals for cell culture-based vaccines, technological advancements, and growth in the biotechnology & pharmaceutical industries in the region are the key factors driving the growth of the cell culture market in North AmericaBreak of primary participants was as mentioned below: By Company Type Tier 136%, Tier 245%, and Tier 319% By Designation C-level33%, Director-level40%, Others27% By Region North America36%, Europe28%, AsiaPacific19%, Latin America-9%, Middle East and Africa8%Key players in the cell culturemarketThe key players operating in the cell culturemarketincludeThermo Fisher Scientific (US), Merck KGaA (Germany), GE Healthcare (US), Danaher Corporation (US), Lonza Group AG (Switzerland), Becton, Dickinson and Company (US), Corning Incorporated (US), Eppendorf (Germany), HiMedia Laboratories (India), Sartorius AG (Germany), PromoCell GmbH (Germany), FUJIFILM Irvine Scientific (US), InvivoGen (US), CellGenix GmbH (Germany), SeraCare Life Sciences Incorporation (US), Miltenyi Biotec (Germany), STEMCELL Technologies, Inc. (Canada), Solida Biotech GmBH (Germany), Caisson Labs Inc. (US), Cellexus Ltd, (UK), PIERRE GURIN (France), Applikon Biotechnology BV (Netherlands), WISENT Inc. (Canada), Koh Jin-Bio Co., Ltd. (Japan), PAN-Biotech GmbH (Germany), and Infors AG (Switzerland).Research Coverage:The report analyzes the cell culturemarketand aims at estimating the market size and future growth potential of this market based on various segments such as product, application, end user, andregion.The report also includes aproduct portfolio matrix of various cell cultureproductsavailable in the market.The report also providesa competitive analysis of the key players in this market, along with their company profiles, product offerings, and key market strategies.Reasons to Buy the ReportThe report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn would helpthem, garner a more significant share of the market. Firms purchasing the report could use one or any combination of the below-mentioned strategies tostrengthen their position in the market.This report provides insights into the following pointers: Market Penetration: Comprehensive information on product portfolios offered by the top players in the global cell culturemarket. The report analyzes this marketby product, application, and end user Product Enhancement/Innovation: Detailed insights on upcoming trends and productlaunches in the global cell culturemarket Market Development: Comprehensive information on the lucrative emerging markets by product, application, and end user Market Diversification: Exhaustive information about new products or product enhancements, growing geographies, recent developments, and investments in theglobal cell culturemarket Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, competitive leadership mapping, and capabilities of leading players in theglobal cell culturemarket.Read the full report: https://www.reportlinker.com/p03665912/?utm_source=GNWAbout ReportlinkerReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.__________________________ CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001

Continue reading here:
Data published in Cancer Research show Secarna Pharmaceuticals' LNAplus(TM) ASOs targeting metadherin significantly slow progression and metastasis of...

Related Posts